Rentschler Biopharma Strengthens U.S. Presence with New Appointment

Rentschler Biopharma SE has appointed Detra Glinatsis as Head of Business Development for the U.S. market. Based in Milford, MA, Glinatsis will steer business development initiatives, reporting to Dr. Patrick Meyer. Her role is pivotal for Rentschler's U.S. commercial strategy, as the company continues to expand its presence in the region, notably through recent project transfers and new product developments at their Milford site.

With over two decades of experience in pharmaceuticals and biotech, Glinatsis returns to Rentschler from Northway Biotech. Her past roles at major industry players underscore her expertise in fostering client relationships. Glinatsis expressed enthusiasm about elevating Rentschler's U.S. brand reputation further.